Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DNF9L1
|
|||
| Drug Name |
Fluorodopa F 18
|
|||
| Synonyms |
Fluorodopa (18F); fluorodopa f-18; FLUORODOPA F 18; fluorodopa F18; 92812-82-3; Fluorine-18-fluoro-L-DOPA; UNII-2C598205QX; 6-((18)F)fluoro-L-DOPA; CHEBI:49166; 2C598205QX; (S)-2-amino-3-(2-(fluoro-18F)-4,5-dihydroxyphenyl)propanoic acid; F-DOPA; 18F-DOPA; (18F)FDOPA; 6-(18F)Fluoro-L-DOPA; L-6-(18F)Fluoro-DOPA; 2-(Fluoro-18F)-L-DOPA; fluorodopa-f-18; Fluorodopa F 18 [USAN:USP:INN]; 2-(Fluoro-18F)-5-hydroxy-L-tyrosine; fluorodopa ((18)F); Fluorodopa F18 (TN); Fluorodopa F 18 (USAN); Fluorodopa (18F) [INN]; SCHEMBL522323; ((18)F)FDOPA; CHEMBL3400972; L-6-((18)F)fluoro-DOPA; DTXSID60239157; MOLI000246; MOLI000965; DB13848; 2-((18)F)fluoro-5-hydroxy-L-tyrosine; 2-(fluoro-(18)F)-5-hydroxy-L-tyrosine; L-Tyrosine, 2-(fluoro-18F)-5-hydroxy-; D04220; L-Tyrosine, 2-(fluoro-(sup 18)F)-5-hydroxy-; 6-((18)F)fluoro-3,4-dihydroxy-L-phenylalanine; 3-(2-fluoro-(18)F-4,5-dihydroxyphenyl)-L-alanine; Q27121509; 3-(2-Fluoro-(sup 18)F-4,5-dihydroxyphenyl)-L-alanine; (2S)-2-amino-3-[2-((18)F)fluoro-4,5-dihydroxyphenyl]propanoic acid
Click to Show/Hide
|
|||
| Drug Type |
Radioactive diagnostic agent
|
|||
| Indication | Diagnostic imaging [ICD-11: N.A.] | Approved | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H10FNO4
|
|||
| Canonical SMILES |
C1=C(C(=CC(=C1O)O)F)CC(C(=O)O)N
|
|||
| InChI |
1S/C9H10FNO4/c10-5-3-8(13)7(12)2-4(5)1-6(11)9(14)15/h2-3,6,12-13H,1,11H2,(H,14,15)/t6-/m0/s1/i10-1
|
|||
| InChIKey |
PAXWQORCRCBOCU-RPDRGXCHSA-N
|
|||
| CAS Number |
CAS 92812-82-3
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:49166
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.